CME Group Inc. (NASDAQ:CME) Receives $224.47 Consensus PT from Analysts

CME Group Inc. (NASDAQ:CME) has earned an average rating of “Hold” from the fifteen analysts that are presently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $224.47.

Several research firms have recently issued reports on CME. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research note on Thursday, October 24th. Bank of America raised their target price on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. Oppenheimer raised their price objective on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. TD Cowen assumed coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target for the company. Finally, The Goldman Sachs Group lifted their target price on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd.

Insider Activity

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 5.38 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the sale, the insider now owns 27,053 shares in the company, valued at approximately $6,131,291.92. This represents a 14.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,028 shares of company stock valued at $1,811,681 in the last ninety days. Insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. PineStone Asset Management Inc. raised its position in CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after purchasing an additional 1,309,097 shares during the period. Franklin Resources Inc. lifted its stake in CME Group by 70.4% during the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after purchasing an additional 1,003,119 shares during the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of CME Group by 577.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after buying an additional 550,133 shares in the last quarter. Ameriprise Financial Inc. grew its position in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares during the last quarter. Finally, International Assets Investment Management LLC increased its position in shares of CME Group by 21,465.5% during the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after purchasing an additional 483,618 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

CME Group stock opened at $238.00 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a market cap of $85.77 billion, a PE ratio of 25.03, a P/E/G ratio of 5.49 and a beta of 0.55. CME Group has a 12-month low of $190.70 and a 12-month high of $238.97. The business’s 50-day moving average price is $225.55 and its two-hundred day moving average price is $211.96.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the company earned $2.25 earnings per share. As a group, analysts expect that CME Group will post 10.22 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 1.93%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.